EUVIMEDObjevte EUVIMED
FallberichtLeserbriefOpen access

Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy

Evan Cantor iD, Rachel Berkovich, Pournima Navalkele, Nicole M Brossier

Pediatric Blood & Cancer · 2023

DOI: 10.1002/pbc.30296 ↗

At a glance

Fallbericht in Pediatric Blood & Cancer, 2023. Written by Evan Cantor and 3 co-authors. Institution: Division of Hematology and Oncology, Connecticut Children's Medical Center, Hartford, Connecticut, USA. Major MEDLINE topics: Ganglioglioma, Brain Neoplasms. Cited 2 times so far (Crossref); 8 references. The full text is freely available in PubMed Central. Funded by: NICHD NIH HHS.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

To the Editor: Gangliogliomas (GG) are composed ofmixed neuronal and glial components and are commonly associated with neurologic symptoms that vary by tumor location. Biologically targeted agents such as the BRAF inhibitors dabrafenib and vemurafenib are now used to treat progressive low-grade gliomas (LGG), including GG,1,2 but the effect of these agents on the neurologic symptoms that may accompany LGGs is poorly understood.3 Here, we describe clinical and radiographic response from single-therapy BRAF inhibition in two patients with

Subjects

MeSH terms (MEDLINE)

GangliogliomaBrain NeoplasmsHumansProto-Oncogene Proteins B-rafMutation

Substances

Proto-Oncogene Proteins B-rafBRAF protein, human

Authors and institutions

  • Division of Hematology and Oncology, Connecticut Children's Medical Center, Hartford, Connecticut, USA.
  • Department of Pediatrics, UCONN School of Medicine, Farmington, Connecticut, USA.
  • Departments of Radiology, Children's Mercy Hospital, Kansas City, Missouri, USA.
  • Division of Pediatric Oncology, Children's Hospital of Orange County, Orange, California, USA.
  • Departments of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA.

ORCID profiles: Evan Cantor

Funding

  • NICHD NIH HHS

Cite

APA

Cantor, E., Berkovich, R., Navalkele, P., & Brossier, N. M. (2023). Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30296

Vancouver

Cantor E, Berkovich R, Navalkele P, Brossier NM. Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30296

BibTeX
@article{Cantor2023,
  author = {Cantor, Evan and Berkovich, Rachel and Navalkele, Pournima and Brossier, Nicole M},
  title = {Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy},
  journal = {Pediatric Blood & Cancer},
  year = {2023},
  doi = {10.1002/pbc.30296}
}
Start for free →